RISS 학술연구정보서비스

검색

인기 검색어

    다국어 입력

    http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

    변환된 중국어를 복사하여 사용하시면 됩니다.

    예시)
    • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
    • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
    닫기

    병용금기 SCREENING 프로그램 시행 후의 처방 분석 = Prescription Analysis after Operation of Incompatible Drug Screening Program

    한글로보기

    https://www.riss.kr/link?id=A105024767

    • 0

      상세조회
    • 0

      다운로드
    서지정보 열기
    • 내보내기
    • 내책장담기
    • 공유하기
    • 오류접수
    인용문이 복사되었습니다.

    부가정보

    다국어 초록 (Multilingual Abstract) kakao i 다국어 번역

    On Jan. 16, 2004, the Ministry of Health & Welfare notified the public of ''Incompatible and specified age limits on medications" that were originally selected by the Health Insurance Review Agency as 162 combinations of incompatible drugs and 10 medications whose use is limited by a specified age range. A special program was designed to discriminate 49 incompatible drug combinations that are used in our hospital that has been in operation since May 1, 2004. When incompatible drug combinations are inputted, warning signs appear. The incompatible drug combinations can be prescribed only when a reason for the prescription is inputted. According to sex, age range, inpatient/ outpatient, department, medication and interaction category, we classified and analyzed the prescription cases of incompatible drug combinations made for four months since the program has been implemented in May thru Aug. 2004. For the above-mentioned period, among 203 prescription cases of incompatible drugs, 50% were for above the age of 60 and 90% were for above the age of 40. Among the cases made by various departments, the department of neurology had the highest rate of 79 cases. Among the combinations of incompatible drugs, there were 41 cases of amitriptyline-selegiline, 28 cases of aspirin-MTX, 26 cases of fluconazole- triazolam, 17 cases of itraconazole-triazolam, 14 cases of selegiline-sertraline, 12 cases of itraconazole-simvastatin, 9 cases of amiodarone-lidocaine. Among the indication categories, combination of MAOI and TCA or SSRI was the highest of 70 cases. The representative reasons for the prescription of the incompatible drugs were "Not controllable with other medications", "Low possibility of side effects with a lower dosage" and "Not simultaneous but with time-interval administration". The ratio of incompatible drug prescriptions given out of the entire prescriptions was 0.038% from May to August in 2003 while it was 0.016% from May to August in 2004, which showed a 58% decrease.
    번역하기

    On Jan. 16, 2004, the Ministry of Health & Welfare notified the public of ''Incompatible and specified age limits on medications" that were originally selected by the Health Insurance Review Agency as 162 combinations of incompatible drugs and 10 medi...

    On Jan. 16, 2004, the Ministry of Health & Welfare notified the public of ''Incompatible and specified age limits on medications" that were originally selected by the Health Insurance Review Agency as 162 combinations of incompatible drugs and 10 medications whose use is limited by a specified age range. A special program was designed to discriminate 49 incompatible drug combinations that are used in our hospital that has been in operation since May 1, 2004. When incompatible drug combinations are inputted, warning signs appear. The incompatible drug combinations can be prescribed only when a reason for the prescription is inputted. According to sex, age range, inpatient/ outpatient, department, medication and interaction category, we classified and analyzed the prescription cases of incompatible drug combinations made for four months since the program has been implemented in May thru Aug. 2004. For the above-mentioned period, among 203 prescription cases of incompatible drugs, 50% were for above the age of 60 and 90% were for above the age of 40. Among the cases made by various departments, the department of neurology had the highest rate of 79 cases. Among the combinations of incompatible drugs, there were 41 cases of amitriptyline-selegiline, 28 cases of aspirin-MTX, 26 cases of fluconazole- triazolam, 17 cases of itraconazole-triazolam, 14 cases of selegiline-sertraline, 12 cases of itraconazole-simvastatin, 9 cases of amiodarone-lidocaine. Among the indication categories, combination of MAOI and TCA or SSRI was the highest of 70 cases. The representative reasons for the prescription of the incompatible drugs were "Not controllable with other medications", "Low possibility of side effects with a lower dosage" and "Not simultaneous but with time-interval administration". The ratio of incompatible drug prescriptions given out of the entire prescriptions was 0.038% from May to August in 2003 while it was 0.016% from May to August in 2004, which showed a 58% decrease.

    더보기

    동일학술지(권/호) 다른 논문

    동일학술지 더보기

    더보기

    분석정보

    View

    상세정보조회

    0

    Usage

    원문다운로드

    0

    대출신청

    0

    복사신청

    0

    EDDS신청

    0

    동일 주제 내 활용도 TOP

    더보기

    주제

    연도별 연구동향

    연도별 활용동향

    연관논문

    연구자 네트워크맵

    공동연구자 (7)

    유사연구자 (20) 활용도상위20명

    인용정보 인용지수 설명보기

    학술지 이력

    학술지 이력
    연월일 이력구분 이력상세 등재구분
    2028 평가 재인증평가 신청대상 (재인증)
    2022-01-01 등재 등재학술지 유지 (재인증) KCI등재
    2019-01-01 등재 등재학술지 유지 (계속평가) KCI등재
    2016-01-01 등재 등재학술지 선정 (계속평가) KCI등재
    2015-01-01 등재 등재후보학술지 유지 (계속평가) KCI등재후보
    2013-01-01 등재 등재후보학술지 유지 (기타) KCI등재후보
    2012-01-01 등재 등재후보학술지 유지 (기타) KCI등재후보
    2010-07-02 학회명변경 한글명 : 병원약사회 -> 한국병원약사회
    영문명 : 미등록 -> The Korean Society of Health-System Pharmacists
    KCI등재후보
    2010-01-01 등재 등재후보학술지 선정 (신규평가) KCI등재후보
    더보기

    학술지 인용정보

    학술지 인용정보
    기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
    2016 0.04 0.04 0.04
    KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
    0.05 0.05 0.27 0
    더보기

    이 자료와 함께 이용한 RISS 자료

    나만을 위한 추천자료

    해외이동버튼